Sysmex (OTCMKTS:SSMXY) Sets New 52-Week Low – Here’s What Happened

Sysmex Corporation ADR (OTCMKTS:SSMXY)’s stock price reached a new 52-week low on Friday . The company traded as low as $8.15 and last traded at $8.49, with a volume of 10282 shares traded. The stock had previously closed at $9.42.

Sysmex Price Performance

The company has a debt-to-equity ratio of 0.11, a quick ratio of 2.49 and a current ratio of 3.34. The stock’s fifty day moving average price is $9.74 and its 200-day moving average price is $11.39. The firm has a market cap of $5.35 billion, a PE ratio of 16.99 and a beta of 1.14.

Sysmex (OTCMKTS:SSMXY) last issued its earnings results on Thursday, February 12th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.14 by $0.01. The company had revenue of $837.32 million for the quarter, compared to analyst estimates of $819.99 million. Sysmex had a net margin of 9.32% and a return on equity of 9.86%. As a group, equities analysts forecast that Sysmex Corporation ADR will post 0.57 EPS for the current fiscal year.

About Sysmex

Sysmex Corporation (OTCMKTS: SSMXY) is a Japan‐based provider of in vitro diagnostic solutions, specializing in haematology, coagulation, urinalysis and immunochemistry systems. Headquartered in Kobe, the company designs and manufactures a comprehensive portfolio of automated analyzers, reagents and software to support clinical laboratories, hospitals and research institutions. Sysmex’s product lineup also includes digital pathology platforms and data management tools that integrate workflow automation and advanced analytics.

The company’s core offerings center on haematology analyzers such as the XN-Series, which deliver high‐speed, high‐volume testing for blood cell counts and differential analysis.